CHEBI:3181 - bromocriptine

ChEBI IDCHEBI:3181
ChEBI Namebromocriptine
Stars
Last Modified22 February 2017
DownloadsMolfile
FormulaC32H40BrN5O5
Net Charge0
Average Mass654.606
Monoisotopic Mass653.22128
SMILES[H][C@@]12Cc3c(Br)nc4cccc(c34)C1=C[C@@H](C(=O)N[C@]1(C(C)C)O[C@]3(O)N(C1=O)[C@@H](CC(C)C)C(=O)N1CCC[C@]13[H])CN2C
InChIInChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1
InChIKeyOZVBMTJYIDMWIL-AYFBDAFISA-N
Wikipedia
Roles Classification
Biological Roles:
hormone antagonist  A chemical substance which inhibits the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.
dopamine agonist  A drug that binds to and activates dopamine receptors.
metabolite  Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
Applications:
antidyskinesia agent  Any compound which can be used to treat or alleviate the symptoms of dyskinesia.
hormone antagonist  A chemical substance which inhibits the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.
dopamine agonist  A drug that binds to and activates dopamine receptors.
antiparkinson drug  A drug used in the treatment of Parkinson's disease.
ChEBI Ontology
Outgoing Relation(s)
bromocriptine (CHEBI:3181) has parent hydride ergotaman (CHEBI:36185)
bromocriptine (CHEBI:3181) has role antidyskinesia agent (CHEBI:66956)
bromocriptine (CHEBI:3181) has role antiparkinson drug (CHEBI:48407)
bromocriptine (CHEBI:3181) has role dopamine agonist (CHEBI:51065)
bromocriptine (CHEBI:3181) has role hormone antagonist (CHEBI:49020)
bromocriptine (CHEBI:3181) is a indole alkaloid (CHEBI:38958)
Incoming Relation(s)
bromocriptine methanesulfonate (CHEBI:3182) has part bromocriptine (CHEBI:3181)
IUPAC Name 
(5'α)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
INNs  Source
bromocriptineChemIDplus
bromocriptinumChemIDplus
Synonyms  Source
2-bromo-α-ergocryptinePatent
2-bromo-α-ergokryptinChemIDplus
2-bromo-α-ergokryptineChemIDplus
(5'α)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotamanIUPAC
(5'α)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trioneChemIDplus
(5'α)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotamanIUPAC
Manual XrefsDatabases
403DrugCentral
BromocriptineWikipedia
C06856KEGG COMPOUND
D03165KEGG DRUG
DB01200DrugBank
DE1926045Patent
LSM-6550LINCS
US3752814Patent
Registry NumbersSources
Beilstein:741357Beilstein
CAS:25614-03-3ChemIDplus
CAS:25614-03-3KEGG COMPOUND